#1 Clinical Trials Search in Europe

Find a Clinical Trial

Search Trials by Disease

Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
Rare Diseases Treatments

Search Trials by Disease

Arrhythmia Giant cell tumour of tendon sheath Mantle cell lymphoma Antisynthetase syndrome Osteosarcoma Vernal keratoconjunctivitis Stargardt's disease Lymphangioma Enteritis Rett syndrome Pulmonary alveolar haemorrhage Uveal melanoma B-cell small lymphocytic lymphoma PIK3CA related overgrowth spectrum Congenital absence of bile ducts More trials…
Learn about Rare Diseases

Gastrointestinal stromal tumour – Trials in Disease Arterial tortuosity syndrome – Treatment Cystic fibrosis lung Cerebral arteriovenous malformation haemorrhagic – Diagnostics Glycogen storage disease type I – Life with Disease Acquired haemophilia – Trials in Disease Hepatoblastoma – Basic Information Richter’s syndrome – Basic Information Adrenocortical carcinoma – Life with Disease Activated PI3 kinase delta syndrome More diseases
Vaccine Clinical Trials
Pediatric Clinical Trials
Resources for Patients

Browse Innovative Treatments

Utreglutide Canis Familiaris (553) Idarubicin Hydrochloride Fluciclovine (18F) E.coli Polysaccharide Lovotibeglogene Autotemcel VOTOPLAM LUXDEGALUTAMIDE XENON (133XE) Fludarabine Azd8205 L-Histidine Levoleucovorin Disodium Phenobarbital SAR444336 GSK5733584 Acetylcysteine Lanifibranor Gallium (68Ga) Mexiletine Hydrochloride More therapies…

Learn about Your Condition

Polyneuropathy Sinusitis bacterial Stress Anaemia of pregnancy Genital herpes SAPHO syndrome Extraskeletal ossification Glucose tolerance impaired Cancer fatigue Pancreatitis acute Lupus nephritis Mantle cell lymphoma stage IV Arrhythmia Familial hypertriglyceridaemia Vertigo More diseases
Healthy Volunteers
Patient Guide
Our Partners
About Us
Contact us
Region

🇪🇺 Europe
🇦🇹 Austria
🇭🇷 Croatia
🇨🇿 Czech Republic
🇩🇰 Denmark
🇪🇪 Estonia
🇫🇮 Finland
🇫🇷 France
🇩🇪 Germany
🇮🇸 Iceland
🇮🇹 Italy
🇱🇻 Latvia
🇱🇹 Lithuania
🇳🇱 Netherlands
🇳🇴 Norway
🇵🇱 Poland
🇵🇹 Portugal
🇷🇴 Romania
🇸🇰 Slovakia
🇸🇮 Slovenia
🇪🇸 Spain
🇸🇪 Sweden

MELAS syndrome

A study testing sonlicromanol in adults with genetically confirmed mitochondrial DNA 3243A>G variant causing mitochondrial disease

Recruiting

3 1
Study on the Safety and Effectiveness of Zagociguat for Treating MELAS in Patients

Not recruiting

2 1
Investigated Drugs:
- Zagociguat
Long-term safety study of zagociguat tablets in patients with MELAS syndrome (Mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes) who completed previous trial

Not recruiting

2 1 1
Investigated Diseases:
- MELAS syndrome
Investigated Drugs:
- Zagociguat
Study on the Effects of TTI-0102 for Patients with MELAS Syndrome

Not recruiting

2 1
Investigated Drugs:
- Mercaptamine-Pantetheine Disulfide Acetate

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

MELAS syndrome

A study testing sonlicromanol in adults with genetically confirmed mitochondrial DNA 3243A>G variant causing mitochondrial disease

Study on the Safety and Effectiveness of Zagociguat for Treating MELAS in Patients

Long-term safety study of zagociguat tablets in patients with MELAS syndrome (Mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes) who completed previous trial

Study on the Effects of TTI-0102 for Patients with MELAS Syndrome

Investigational Drugs in This Location

Medical Conditions Being Studied in This Location

We use cookies